kelly responds to questions, page-2

Hey Alpha,

What do you make of Dr Kelly's last para.

"That of course assumes that the SPA statistical needs are met. But given that the study has been terminated with only about two-thirds of the minimum amount of required data available for analysis, the more likely scenario is that the statistical outcome will fall short of the required level. Just how short then will determine how long (and if) the FDA would take to review the data."

Is this a suggestion that the OVATURE study may fail?

Skippa